NCT03375944

Brief Summary

Although clinical data demonstrate advantages of combining complete revascularization with optimal cardiac rehabilitation (CR) less than one-third of patients in European countries participate in cardiac rehabilitation programs. Therefore, in cooperation with Polish leaders in cardiovascular medicine, rehabilitation and medical software design we aim to introduce and evaluate the system of optimal cardiac telerehabilitation in addition to optimal treatment of coronary artery disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 18, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 28, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

1.7 years

First QC Date

December 12, 2017

Last Update Submit

May 28, 2018

Conditions

Keywords

Cardiac tele-rehabilitation, Myocardial revascularization

Outcome Measures

Primary Outcomes (2)

  • All cause mortality

    The primary objective of the study is to compare the all cause mortality between the control and the study group during the annual follow-up.

    12 months

  • All cause mortality

    The primary objective of the study is to compare the all cause mortality between the control and the study group during the 9-month follow-up.

    9 months

Secondary Outcomes (6)

  • Rate of major adverse coronary and cerebrovascular events (MACCE)

    9 months and 1 year

  • rate of target vessel failure (TVF)

    9 months and 1 year

  • cardiac death

    9 months and 1 year

  • Length of hospital stay

    up to 9 months and 1 year

  • Regression, stabilisation or progression of atherosclerotic plaques

    baseline + up to 1 year follow-up

  • +1 more secondary outcomes

Study Arms (2)

control group

NO INTERVENTION

Cardiac supervision

study group

OTHER

Cardiac supervision and rehabilitation

Other: Rehabilitation

Interventions

The purpose of this work package is to evaluate short- and long-term clinical effects of optimal, continuous and regularly controlled tele-rehabilitation, which is based on exercise training, intensive dietary and educational program focused on lifestyle and risk factors modification. The main expectations of OCR is to normalize annual mortality to the level of the low risk "healthy" population.

study group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 and below 70
  • completed revascularization in patients with stable or unstable angina or after myocardial infarction without ST-segment elevation (NSTEMI)
  • in patients with suspected myocardial scars, MRI will be recommended to confirm myocardial viability.
  • eligibility to participate in a program of early cardiac rehabilitation
  • signed informed consent form
  • the ability to use telerehabilitation system

You may not qualify if:

  • acute myocardial infarction with ST segment elevation/new onset of left bundle branch block (LBBB),
  • suboptimal (not completed) revascularisation
  • ejection fraction \<40%.
  • acute heart failure (Killip IV) at the time of admission to the hospital
  • dual antiplatelet therapy can not be maintained for 1 year after PCI
  • haemorrhagic stroke in the past
  • ischemic stroke or transient ischemia in previous 6 weeks
  • platelet count \<100,000 / mm3
  • chronic renal failure with creatinine clearance \<30ml / min / 1.73m2
  • planned surgery
  • pregnancy or planned pregnancies
  • expected life expectancy less than 3 years after enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Malopolskie Centrum Sercowo-Naczyniowe

Chrzanów, Lesser Poland Voivodeship, 32-500, Poland

ACTIVE NOT RECRUITING

IV Oddział Kardiologii Inwazyjnej, Elektrostymulacji i Angiologii

Kedzierzyn Kozle, Lower Silesian Voivodeship, 47-200, Poland

ACTIVE NOT RECRUITING

II Oddział Kardiologiczny

Bielsko-Biala, Upper Silesia, 43-316, Poland

ACTIVE NOT RECRUITING

III Oddział Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii

Dąbrowa Górnicza, Upper Silesia, 41-300, Poland

ACTIVE NOT RECRUITING

X Department of Interventional Cardiology

Tychy, Upper Silesia, 43-100, Poland

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease, Autosomal Dominant, 1

Interventions

Rehabilitation

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Krzysztof Milewski, MD PhD

    American Heart of Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Krzysztof Milewski, MD PhD

CONTACT

Dominika Baron, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Executive Officer

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 18, 2017

Study Start

March 28, 2018

Primary Completion

December 1, 2019

Study Completion

July 1, 2020

Last Updated

May 30, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations